drugset
drugset / Trial / NCT03113058

"Treatment of Active HBV With γδT Cells" Clinical Trial Protocol

NCT03113058 ↗

Phase 0 Unknown 60 enrolled Jinan University Guangzhou Guagnzhou Qiaokang Hospital · collab
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the safety and anti-HBV efficacy of γδT cells.

Timeline

Start
2017-05-02
Primary completion
2018-10-05
Completion
2018-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject γδ T cells Cell therapy — Intravenous

Indications

No indication recorded.